Evidence map›Paper›PMID 40959790›Full record

ArticleIJTLD open2025

TB treatment support strategies for children, adolescents, and young adults in a low-incidence setting.

A R Verhage, A C Hesseling, G H Koppelman, H A M Kerstjens, O W Akkerman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A R VerhageDepartment of Paediatric Infectious Diseases and Immunology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A C HesselingDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
G H KoppelmanDepartment of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H A M KerstjensGroningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
O W AkkermanDepartment of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally, TB programmes should pay attention to the treatment support needs of children and adolescents (0-24 years) given the high disease burden and specific care requirements. We examine how health care workers in a low-incidence setting monitor and support TB treatment and TB preventive treatment (TPT) in this population.

methodsA quantitative web-based cross-sectional survey was conducted from 1 December 2023 to 31 January 2024 among Dutch health care workers routinely caring for persons (0-24 years) in community- and hospital-based TB services.

resultsNinety-three health care workers participated. The most common strategies to monitor TB treatment and TPT were 1) verbal questioning on adherence (100% vs. 99%) and 2) evaluating clinical response to TB treatment (91%). Additional strategies were always used for TB treatment, with a pill organiser being the preferred method, while 50% seldom used extra strategies for TPT. Digital support technologies were rarely used for TB treatment and TPT by 78% and 90% of respondents, respectively.

conclusionDutch health care workers relied on traditional methods to support TB treatment adherence with limited use of digital technologies and greater focus on disease than infection. Further research is needed to assess whether these strategies meet young people's needs in TB care and improve outcomes.

Indexed as

monitoringsupporttreatment adherencetuberculosis

Identifiers

PMID40959790
PMCPMC12435468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.